Year Established :
2019
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
10-50
Main Competitive Advantages :
Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages :
The company has independently developed its own vortex flow reactor for conducting gas, liquid and solid full-phases chemical reactions. This reactor technology can be applied in the manufacturing processes of various pharmaceuticals and its intermediates due to its effectiveness in dealing with extremely strong exothermic reactions and heterogeneous reactions and solving scale-up issue of chemical reaction process. This technology has the advantages of small floor area, high degree of automation, adjustable reaction and so on, which makes up for the performance gap between the traditional stirred reactor, tubular reactor and micro-reactor. It can meet the diversified needs of the pharmaceutical manufacturing industry, which become one of the development directions of the intelligent upgrading of pharmaceutical manufacturing.
Business Type :
All,Trading Company,Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Asia,Middle East,Africa
Product Range :
Haigine's main service scope:
1. Nitro compounds, cyanogen compounds, fluorine / bromine compounds, specific heterocyclic compounds (pyrrole, pyrazole)
2. Products related to epoxidation / hydrogen peroxide and other oxidation processes, hydrogenation products
3. Flow chemical reaction equipment
Audited Supplier
Pharma Sources Insight JANUARY 2024
